PB1910: TELAGLENASTAT (CB-839) IN MONOTHERAPY AND IN COMBINATION WITH EPIGENETIC MODULATORS OR IBRUTINIB INDUCES CELL DEATH IN CHRONIC LYMPHOCYTIC LEUKEMIA CELLS
Joana Jorge,
Hugo Santiago,
Beatriz Constantino,
Maria Inês Costa,
Beatriz Lapa,
Raquel Alves,
Ana Cristina Gonçalves,
Ana Bela Sarmento-Ribeiro
Affiliations
Joana Jorge
1 Faculty of Medicine (FMUC), University of Coimbra, Laboratory of Oncobiology and Hematology (LOH) and University Clinic of Hematology and Oncology, Coimbra, Portugal
Hugo Santiago
1 Faculty of Medicine (FMUC), University of Coimbra, Laboratory of Oncobiology and Hematology (LOH) and University Clinic of Hematology and Oncology, Coimbra, Portugal
Beatriz Constantino
1 Faculty of Medicine (FMUC), University of Coimbra, Laboratory of Oncobiology and Hematology (LOH) and University Clinic of Hematology and Oncology, Coimbra, Portugal
Maria Inês Costa
1 Faculty of Medicine (FMUC), University of Coimbra, Laboratory of Oncobiology and Hematology (LOH) and University Clinic of Hematology and Oncology, Coimbra, Portugal
Beatriz Lapa
1 Faculty of Medicine (FMUC), University of Coimbra, Laboratory of Oncobiology and Hematology (LOH) and University Clinic of Hematology and Oncology, Coimbra, Portugal
Raquel Alves
1 Faculty of Medicine (FMUC), University of Coimbra, Laboratory of Oncobiology and Hematology (LOH) and University Clinic of Hematology and Oncology, Coimbra, Portugal
Ana Cristina Gonçalves
1 Faculty of Medicine (FMUC), University of Coimbra, Laboratory of Oncobiology and Hematology (LOH) and University Clinic of Hematology and Oncology, Coimbra, Portugal
Ana Bela Sarmento-Ribeiro
1 Faculty of Medicine (FMUC), University of Coimbra, Laboratory of Oncobiology and Hematology (LOH) and University Clinic of Hematology and Oncology, Coimbra, Portugal
